Grupo Fleury Streamlines Demand Planning with FICO Platform

FICO | March 28, 2019

article image
Grupo Fleury, one of Brazil’s largest diagnostic medicine companies, has created an automated demand planning management platform – the Fleury Forecaster.  Using FICO® Xpress Insight, Group Fleury has slashed the time needed to create a sales forecast. Forecasts have also become more accurate and granular in detail, with the overall margin of error now less than 10 percent.

Spotlight

Healthcare Services Group, Inc

Since 1976, Healthcare Services Group has delivered exceptional housekeeping, laundry, dining and nutrition services to an ever-changing healthcare industry. Headquartered in Bensalem, PA, we provide professional management of ancillary services to a diverse mix of satisfied clients. A health care facility derives many benefits from operating a spotlessly clean, aesthetically pleasing environment. Our staff is thoroughly trained to perform housekeeping, laundry, linen, facility management and food responsibilities with skill and sensitivity. Stringent quality-assurance standards insure that a facility will receive the most professional services in the industry.

OTHER ARTICLES

Merck’s Patient-Centric Clinical Trial Recruiting

Article | March 4, 2020

Everyone in pharma knows that product success depends on the results of clinical trials — but we don’t usually hear from the people who are involved in running them. Recently, four Clinical Research Managers (CRM) from Merck (known as MSD outside the United States and Canada) discussed how Merck is overcoming the barriers to clinical trial recruitment by adopting a patient-centric process — a model that affects their trials top to bottom, from design through implementation. Each of the panel members manages clinical trials, serving as the main point of interaction with the Clinical Research Associates (CRAs) on research requirements, goals, and resources, including recruiting and retention.

Read More

How Can Medical Cannabis Help to Manage Pain Conditions? – The Cannabis Exchange

Article | February 11, 2020

Pain management is one of the most common reasons for the use of medical cannabis products. However, despite many jurisdictions – including Canada, Germany, and the Netherlands – now allowing the prescription of medical cannabis for this purpose, there remains little ‘high-quality’ evidence to support, or oppose its efficacy. Madden et al. (2018) set out to review the evidence available in order to determine the efficacy of medical cannabis when employed in the management of various forms of musculoskeletal pain. The researchers analysed various studies that assessed the use of cannabinoids in the treatment of arthritis pain; back pain; postoperative pain; and trauma-related pain. It is estimated that up to 30% of the population may suffer from a non-cancer-related pain condition. As such a high percentage of people suffer from these conditions, the development of simple and safe therapies is an essential area of research. This is particularly important as the therapeutic options for people with chronic pain are increasingly limited.

Read More

Pricing of drugs – at what cost?

Article | February 27, 2020

We go into a doctor’s office and leave with a diagnosis and a prescription. Next we stop by the pharmacy. In Germany, if your insurance is not private, you mostly don’t even know the price of your drug because it’s paid for directly by your insurance. You only notice the 5-10 Euros copay. But how is a drug priced in Germany? And (how) does data play a role in helping pharma secure an attractive price point? Let’s fast forward directly to the launch of a new drug. At the time of launch, the pharmaceutical company has to present patient level evidence of the drug’s added value compared to existing comparative therapies. In the first year, however, the drug’s price can be defined freely by the company.

Read More

Roche Prepares to Launch COVID-19 Antibody Test System

Article | April 17, 2020

Swiss pharma giant Roche is joining the race to develop a test for COVID-19 antibodies in people who have been exposed to the disease. This morning, Roche announced the development and upcoming launch of its Elecsys Anti-SARS-CoV-2 serology test to detect antibodies in people who have been exposed to the SARS-CoV-2, the virus that causes COVID-19. Roche is eying May for the launch of the test in Europe and is in talks with the U.S Food and Drug Administration for emergency approval of the system. Antibody testing is central to help identify people who have been infected by the virus, especially those who may have been infected but did not display symptoms, the company said. Roche noted that as more information becomes available about immunity levels to COVID-19, society can return to a sense of normal much more quickly. Roche’s test will join a number of other antibody tests that have recently come on the market. Earlier this month the U.S. Food and Drug Administration approved the first blood test for COVID-19 antibodies.

Read More

Spotlight

Healthcare Services Group, Inc

Since 1976, Healthcare Services Group has delivered exceptional housekeeping, laundry, dining and nutrition services to an ever-changing healthcare industry. Headquartered in Bensalem, PA, we provide professional management of ancillary services to a diverse mix of satisfied clients. A health care facility derives many benefits from operating a spotlessly clean, aesthetically pleasing environment. Our staff is thoroughly trained to perform housekeeping, laundry, linen, facility management and food responsibilities with skill and sensitivity. Stringent quality-assurance standards insure that a facility will receive the most professional services in the industry.

Events